Neurology · 2002 · 116 citations · 21 references
Life SciencesGeneticsMolecular GeneticsHuman GeneticsMedical GeneticsNeurogeneticsGenetic DisordersGenetic SyndromesMovement Disorder GeneticsNeurogenetic DisordersAutosomal Dominant InheritanceD2-like Dopamine ReceptorsDisease Gene SegregationDopamine D2-like ReceptorsHaplotype Frequency AnalysisLod Score AnalysisLoss-of-function MutationsMicrosatellite Marker Analysis
OBJECTIVE: Inherited myoclonus-dystonia (IMD) is a new term for an autosomal dominant disorder characterized by myoclonus and dystonia. Recently, IMD was linked to a region on chromosome 11q23 with two different mutations identified in the D2 dopamine receptor gene and linked to chromosome 7q with five different loss-of-function mutations identified in the epsilon-sarcoglycan gene. METHODS: These two regions and genes were excluded in a large Canadian family with IMD in whom 13 individuals are affected. A 25-cM genome scan of this large family with 32 individuals was performed. RESULTS: Two-point linkage analysis revealed a maximum lod score of 3.5 (recombination fraction 0.00; affected only) for the microsatellite marker GATA185C06-18 and a multipoint lod score of 3.9 across the 18p11 region. Haplotype analysis demonstrates that all the affected individuals shared a common haplotype between markers D18S1132 and D18S843 that defines the disease gene within a span of 16.9 cM. CONCLUSIONS: These findings indicate that a novel IMD gene exists on chromosome 18p11.
21
Multilocus linkage analysis in humans: detection of linkage and estimation of recombination.
G.M. Lathrop, J.-M. Lalouel, Cécile Julier et al. · PubMed · 1985 · 1.2K citations
Localization of a gene for myoclonus-dystonia to chromosome 7q21-q31
Torbjoern G. Nygaard, Deborah Raymond, Caiping Chen et al. · Annals of Neurology · 1999 · 112 citations
Life Sciences, Genetics, Neurology +13